The Wall Street Journal
ZURICH—Roche Holding AG Thursday said its cancer drug Avastin showed positive results in the treatment of advanced ovarian cancer, further improving the prospects of one of the Swiss pharmaceutical company's best-selling drugs.
Roche, which earlier this week registered a setback with Avastin in the treatment of stomach cancer, said a late stage trial found that the drug—in combination with chemotherapy plus maintenance use of Avastin—increases the time women live without the disease becoming... read more (access is restricted)
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
